Daiichi Sankyo Company, Limited (4568.T) is in Healthcare, Drug Manufacturers - General, based in Japan, listed on Tokyo. Market cap 4.77T JPY. 52-week range 2,390.00 to 4,170.00 JPY. Trailing P/E 19.0. Data as of 2026-10-09.
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3, as well as symptomatic TGCT; Vanflyta, a FLT3 inhibitor ...